Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andras Perl

Showing results (51-60 of 149) with videos related to

Pageof 15
Sort By:
Medical Review (2021)|January 29, 2024
The mTOR pathway in the antiphospholipid syndromeLanlan Ji, Zhuoli Zhang, Andras Perl
Clinical Immunology (Orlando, Fla.)|July 28, 2012
Metabolic regulation of organelle homeostasis in lupus T cellsTiffany N Caza, Gergely Talaber, Andras Perl
Frontiers in Immunology|October 20, 2023
Editorial: Mitochondrial dysfunction in inflammation and autoimmunityJens Staal, Luz Pamela Blanco, Andras Perl
Clinical Immunology (Orlando, Fla.)|April 12, 2015
Oxidative stress and Treg depletion in lupus patients with anti-phospholipid syndromeZhi-wei Lai, Ivan Marchena-Mendez, Andras Perl
The Journal of Clinical Psychiatry|June 13, 2012
Psychiatric symptoms in systemic lupus erythematosus: a systematic reviewZsuzsa Szombathyne Meszaros, Andras Perl, Stephen V Faraone
Clinical Immunology Communications|April 15, 2024
Appraising SARS-CoV-2 infections after full mRNA COVID-19 vaccination in patients with systemic lupus erythematosus (SLE)Anderson Anuforo, Michael Sandhu, Jianghong Yu, et al.
Free Radical Biology & Medicine|April 28, 2007
Nitric oxide, mitochondrial hyperpolarization, and T cell activationGyorgy Nagy, Agnes Koncz, David Fernandez, et al.
Antioxidants & Redox Signaling|September 7, 2002
Metabolic switches of T-cell activation and apoptosisAndras Perl, Peter Gergely, Ferenc Puskas, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Signaling abnormalities in systemic lupus erythematosus as potential drug targetsDavid Fernandez, Eduardo Bonilla, Paul Phillips, et al.
Clinical Immunology (Orlando, Fla.)|March 23, 2020
Nine-test panel has superior sensitivity to detect antiphospholipid antibody syndrome in patients with or without SLEKonrad Dziamski, Saika Sharmeen, Katalin Banki, et al.
Pageof 15

Showing results (51-60 of 149) with videos related to

Sort By:
Pageof 15
Medical Review (2021)|January 29, 2024
The mTOR pathway in the antiphospholipid syndromeLanlan Ji, Zhuoli Zhang, Andras Perl
Clinical Immunology (Orlando, Fla.)|July 28, 2012
Metabolic regulation of organelle homeostasis in lupus T cellsTiffany N Caza, Gergely Talaber, Andras Perl
Frontiers in Immunology|October 20, 2023
Editorial: Mitochondrial dysfunction in inflammation and autoimmunityJens Staal, Luz Pamela Blanco, Andras Perl
Clinical Immunology (Orlando, Fla.)|April 12, 2015
Oxidative stress and Treg depletion in lupus patients with anti-phospholipid syndromeZhi-wei Lai, Ivan Marchena-Mendez, Andras Perl
The Journal of Clinical Psychiatry|June 13, 2012
Psychiatric symptoms in systemic lupus erythematosus: a systematic reviewZsuzsa Szombathyne Meszaros, Andras Perl, Stephen V Faraone
Clinical Immunology Communications|April 15, 2024
Appraising SARS-CoV-2 infections after full mRNA COVID-19 vaccination in patients with systemic lupus erythematosus (SLE)Anderson Anuforo, Michael Sandhu, Jianghong Yu, et al.
Free Radical Biology & Medicine|April 28, 2007
Nitric oxide, mitochondrial hyperpolarization, and T cell activationGyorgy Nagy, Agnes Koncz, David Fernandez, et al.
Antioxidants & Redox Signaling|September 7, 2002
Metabolic switches of T-cell activation and apoptosisAndras Perl, Peter Gergely, Ferenc Puskas, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Signaling abnormalities in systemic lupus erythematosus as potential drug targetsDavid Fernandez, Eduardo Bonilla, Paul Phillips, et al.
Clinical Immunology (Orlando, Fla.)|March 23, 2020
Nine-test panel has superior sensitivity to detect antiphospholipid antibody syndrome in patients with or without SLEKonrad Dziamski, Saika Sharmeen, Katalin Banki, et al.
Pageof 15